)
Table of contents :
|
|
|
,
which causes local supersaturation and crystallization of calcium and magnesium
phosphates as carbonate apatite (Ca10(PO4)6
.
CO3)
and struvite (MgNH4PO4
.
6H2O),
respectively. This effect may also be enhanced by bacterial LPS : macromolecules
of such kind contain negatively charged residues that are able to bind
Ca2+ and Mg2+, leading to the accumulation of these
ions around bacterial cells, either enhancing or inhibiting the crystallization
of struvite and apatite, depending on its chemical structure and ability
to bind cations
associated with high urinary pH.
Patients with struvite stones may present with acute flank pain or remain
completely asymptomatic.
if ureteral catheter obstruction or percutaneous nephrostomy
(useless in ureteral lithiasis unless ureter is dilated)
for terminal ureter
(location, size, morphology, and parenchymal cavities) : if patient has
renal
failure replace with ascending
(urethrocystouretero)pyelography
and urease-inhibitors (acetohydroxamic acid and fluorofamide) in urinary
infection stones
(risk of perirenal hematomas),
local pain, and tenderness on pressure
),
and intracranial
aneurysm.
It occurs in 2 unrelated forms :.
In older children cystic and fibrotic disease of the liver may be associated.
CDK
inhibitor
roscovitine is effective in murine modelsref
after adolescence
or necropsy, located in the cortex, solitary or multiple, with number
increasing with age; no malignant transformation; when very large they
may break or cause compression atrophy
in disseminated
intravascular coagulation
causes acute cortical necrosis (whole renal cortex is involved)
due to or associated with renal disease with a factor of parenchymal ischemiaref
is positive only when the homolateral kidney is analyzed in 2 separate
regions
confirms severe stenosis in the upper branch of the homolateral renal artery
due to insertion/deletion polymorphism in intron 16)
in the first third (most) or ostium (30%) of renal artery (55-70%, > 90%
in elderlies), bilateral in 33%),
coronary
arterial disease (CAD),
and sometimes systemic
arterial hypertension
experimentally induced with clamping that causes a Goldblatt kidney). The
ischemic kidney incretes more renin => hyperreninemic
hyperaldosteronism
=> systemic vasoconstriction => systemic
arterial hypertension.
The contralateral kidney has renin incretion suppressed and pressure
natriuresis.
reduces filtration in the unaffected kidney => hypercreatininemia
(sensitivity = 80-85%, usually diagnosed as >/< 60%; specificity = 90-95%)
detects dimensional asymmetry of kidneys with conserved normal
shape (differential diagnosis with tubulointerstitial
nephropathies where scars deformate renal parenchyma)
(not nephrotoxic contrast enhancement agent : can't assess distal segments
of renal artery => reduced sensitivity in fibrodysplasia, poor visualization
of small accessory renal arteries, artifacts in presence of stents)
(pay attention to contrast enhancement media chosen !)
(nephrotoxic contrast enhancement agent; preferred to MRA in patients with
stents)
or AT1a antagonists
don't prevent nephrosclerosis and may cause ARF in patients with bilateral
stenosis or single kidney with stenotic renal artery => diuretics
+ b1-blockers
or a1/b1-blockers
OR CCBs
(PTRAS) (efficacy similar to classical surgery) in ostial atherosclerotic
stenoses or in restenosis after PTRA.
Onset occurs a few weeks (differential diagnosis with ATN
!) after angiography
(2% : aortography, arteriography), angioplasty, or vascular surgery and
maybe spontaneous or after antiplatelet
or thrombolytic
therapy due to inference in plaque healing.
,
eosinophils in urine sediment.
(decrease foreign body reaction ?) allow improvement (differential diagnosis
with ATN which is self-limiting
within 3 days and leads to full recovery within 1 week)
,
pallor
(defined a posteriori as cured or improved by tratment of renovascular
disease)
(sensitivity = 83-95%; specificity = 81-100%).
Cyclosporine, cyclophosphamide, plasmapheresis, protein A immunoabsorption,
and mycophenolate mofetil have been variably effectiveref1,
ref2
: recurs in about 30% of patients who undergo for this condition and leads
to the nephrotic syndrome and accelerated
graft lossrefref
in individuals with VEGF
I allele (-2549 promoter SNP) and Z+2 5'aldose-reductase-like
(ALDRL2) allele in which there is glomerular mesangial expansion
with either,
systemic
arterial hypertension,
chronic
renal failure, and retinopathy
,
microangiopathies, and scleroderma
common in old age
(hypertensive nephrosclerosis),
with insidious onset, cylindruria, edema,
hypertrophy of the heart, degeneration of the renal tubules, and glomerulonephritis,
resulting in chronic renal failure,
congestive
heart failure (CHF),
and cerebral hemorrhage.
2 types are distinguished;
in younger persons, it may occur in patients with diabetes
mellitus
with a predisposition to arteriosclerosis and in those with systemic
arterial hypertension
resulting from an apparent underlying disease such as pheochromocytoma.
and hyperplastic
arteriolosclerosis.
It may occur without previous hypertension or superimposed on benign hypertension
or primary renal disease, especially glomerulonephritis,
benign
arteriolar nephrosclerosis, or pyelonephritis
alone or in combination with an ACEI
or an angiotensin receptor blocker (ARB), are more effective than dihydropyridine
calcium antagonists (DCA) in treatment of hypertensive nephropathyrefwith
reduction
of differential blood pressure => further renal damage via both ischemia
and glomerular hypertension => tubular hypertension => interstitial hypertension
=> activation of fibroblasts => fibrosis)
: decreased CO => systemic
arterial hypotension
=> increased RAA system activation => cardiogenous edema
:
in late stages
(Löhlein-Baehr
lesion : necrosis and hyalinization)
(linear IIF pattern),
lung
cancers
and melanoma,
secondary
syphilis,
congenital
syphilis,
Plasmodium
spp.,
HBV,
HCV)
+ LRPAP1)
derived from tubule brush borders, which causes an autoimmune reaction
by the native tubules)ref.
Megalin is a large (approximately 600 kD) glycoprotein belonging to the
LDL receptor gene familyref,
located at the clathrin-coated pits, internalizing the ligands into the
endocytic compartments, and recycled to the cell surfaceref1,
ref2.
It is expressed abundantly at the apical membranes of proximal tubule cells
(PTC) that normally reabsorb and metabolize low–molecular weight proteins
(LMWP) filtered by glomeruliref.
Megalin is known to serve as a major receptor for endocytosis of multiple
LMWP, including transcobalamin-B12ref,
vitamin D-binding proteinref,
retinol-binding proteinref,
parathyroid hormoneref,
insulin, b2-microglobulin (b2-m),
epidermal growth factor, prolactin, lysozyme, cytochrome cref,
a1-microglobulin,
PAP-1, odorant-binding proteinref,
transthyretinref,
and advanced glycation end products (AGE)ref.
In renal failure, LMWP accumulate in serum and tissues; some of them, such
as b2-m causing dialysis-related
amyloidosis (DRA)ref,
act as uremic toxin proteins associated with complications in patients.
Parathyroid hormone is also recognized as a uremic toxinref.
Megalin thus appears to be a useful therapeutic molecular tool to remove
such uremic toxin proteins in uremia, and a novel cell therapy model has
been recently developed by subcutaneous implantation of megalin-expressing
cells to metabolize b2-m in renal
failureref.,
ssRNA via TLR7ref)
with chills
=> nephrotic syndrome
(detected also with IF)
(urinary schistosomiasis)
(usually type II),
Henoch-Schonlein
purpura)
,
but few, if any, immune deposits
: amyloid deposits within mesangium and below glomerular endothelium =>
crosslinked glycated proteins entrap nonglycated proteins (e.g. albumin)
and increase capillary permeability => stimulation of fibroblast proliferation
=> increased ECM synthesis
(ALA).
The morphological findings have been classified into 6 subgroups by the
WHO in 1992 (15 glomeruli / biopsy) :
and cyclophosphamide.
and cyclophosphamide,
hemodialysis..